“…Considering those characteristics of a macrocyclic complex and the possibility to develop a variety of new NO donors that offer several advantages over conventional NO donors, that we believe in [RuCl(tetraazamacrocycle)NO] 2+ complexes as possible nitric oxide donor agents. In fact, the thermodynamic, kinetic and some pharmacological properties of [RuL(macrocycle)NO] n+ complexes where the macrocycle is cyclam (cyclam = 1,4,8,11-tetraazacyclotetradecane) [26][27][28], dioxocyclam [28] or [15]aneN 4 (1,4,8,12-tetraazacyclopentadecane) [16,29,30] have been described. Apparently all the studied complexes show great capability to function as NO delivery agents by having accessible reduction potentials that result in NO release [16,[25][26][27][28][29][30].…”